Cells traffic in both directions between the fetus and the mother during pregnancy. Recent studies indicate that a low level of fetal cells commonly persists in the maternal circulation for years after pregnancy completion.The harboringof DNA or cells from another individual at low levels is called microchimerism. Chronic graft-vs-host disease is a condition of human chimerism that shares similaritiesto some autoimmune diseasesand for which the specific HLA genes of donor and host are known to be of central importance. Considered together with the female predilection to autoimmunity, these observations led to the hypothesis that microchimerism and HLA genes of host and non-host cells are involved in autoimmune disease. The hypothesis also extends to men and females who have not been pregnant because there are other sources of microchimerism. Maternal cells are now know to persist in her progeny and microchimerism can also derive from a twin or from a blood transfusion. Studies of systemic sclerosis, primary biliary cirrhosis, Sjögrens syndrome, polymorpyhic eruption of pregnancy, myositis and thyroid disease have both lent support and raised doubts about the role of microchimerism in autoimmune disease.
Lo YMD , Lau TK , Chan LYS , Leung TN , Chang AMZ . Quantitative analysis of the bi-directional fetomaternal transfer of nucleated cells and plasma DNA . Clin Chem2000; 46: 1301–1309 .
2.
Bianchi DW , Zickwolf GK , Weil GJ , Sylvester S , DeMaria MA . Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum . Proc Natl Acad Sci1996; 93: 705–708 .
3.
Rouquette-Gally AM , Boyeldieu D , Gluckman E , Abuaf N , Combrisson A . Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjögren syndrome and scleroderma . Br J Hematol1987; 66: 45–47 .
4.
Nelson JL . Maternal–fetal immunology and autoimmune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune?Arthritis Rheum1996; 39: 191–194 .
5.
Hall JM , Lingenfelter P , Adams SL , Lasser D , Hansen JA , Bean MA . Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization . Blood1995; 86: 2829–2832 .
6.
Petit T , Dommergues M , Socie G , Dumez Y , Gluckman E , Brison O . Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification . Br J Hematol1997; 100: 767–771 .
7.
Lo ESF , Lo YMD , Hjelm NM , Thilaganathan B . Transfer of nucleated maternal cells into fetal circulation during the second trimester of pregnancy . Br J Hematol1998; 100: 605–606 (Letter).
8.
Maloney S , Smith AG , Furst DE et al. Microchimerism of maternal origin persists into adult life . J Clin Invest1999; 4: 41–47 .
9.
De Moor G , De Bock G , Noens L , De Bic S . A new case of human chimerism detected after pregnancy: 46,XY karyotype in the lymphocytes of a woman . Acta Clin Belg1988; 43: 231–235 .
10.
Lee TH , Paglieroni T , Ohto H , Holland PV , Busch MP . Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients. Frequent long-term microchimerism in severe trauma patients . Blood1999; 93: 3127–3139 .
11.
Bianchi DW , Farina A , Weber W et al. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism . Am J Obstet Gynecol2001; 184: 703–706 .
12.
Nelson JL , Furst DE , Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in SSc . Lancet1998; 351: 559–562 .
13.
McMilin KD , Johnson RL . HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease . Transfus Med Rev1993; 7: 37–41 .
14.
Artlett CM , Smith JB , Jimenez, SA . Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis . New Engl J Med1998; 338: 1186–1191 .
15.
Nelson JL . Microchimerism and autoimmune disease . New Engl J Med1998; 338: 1224–1225 .
16.
Evans PC , Lambert N , Maloney S , Furst DE , Moore JM , Nelson JL . Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma . Blood1999; 93: 1–6 .
17.
Murata H , Nakauchi H , Sumida T . Microchimerism in Japanese women patients with systemic sclerosis . Lancet1999; 354: 220-220 .
18.
Miyashita Y , Ono M , Ono M , Ueki H . Y chromosome microchimerism in rheumatic autoimmune disease . Ann Rheum Dis2000; 59: 655–666 (Letter).
19.
Ichikawa N , Kotake S , Hakoda M , Kamatani N . Microchimerism in Japanese patients with systemic sclerosis . Arthritis Rheum2001; 44: 1226–1228 .
20.
Artlett C , Cox L , Jimenez SA . Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens . Arthritis Rheum2000; 43: 1062–1067 .
21.
Christner PJ , Artlett CM , Conway RF and Jimenez SA . Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride . Arthritis Rheum2000; 43: 2598–2605 .
22.
Kirby J , Nelson JL , Furst DE et al. Fetal cell microchimerism in multiple tissues from multiple sites in women with systemic sclerosis . Arthritis Rheum2001; 44: 1848–1854 .
23.
Aractingi S , Berkane N , Bertheau P et al. Fetal DNA in skin of polymorphic eruptions of pregnancy . Lancet1999; 352: 1898–1901 .
24.
Fanning PA , Jonsson JR , Clouston AD et al. Detection of male DNA in the liver of female patients with primary biliary cirrhosis . J Hepatol2000; 33: 690–695 .
25.
Tanaka A , Lindor K , Gish R et al. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis . Hepatology1999; 30: 833–838 .
26.
Corpechot C , Barbu V , Chazouilleres O , Poupon R . Fetal microchimerism in primary biliary cirrhosis . J Hepatol2000; 33: 696–700 .
27.
Invernizzi P , De Andreis C , Sirchia SM et al. Blood fetal microchimerism in primary biliary cirrhosis . Clin Exp Immunol2000; 122: 418–422 .
28.
Rubbia-Brandt L , Philppeux MM , Chavez S , Mentha G , Borisch B , Hadengue A . FISH for Y chromosome in women with primary biliary cirrhosis: lack of evidence for leukocyte microchimerism . Hepatology1999; 30: 821-821 (Letter).
29.
Klintschar M , Schwaiger P , Mannweiler S , Regauer S , Kleiber M . Evidence of fetal microchimerism in Hashimoto's thyroiditis . J Clin Endocrinol Metab2001; 86: 2494–2498 .
30.
Srivatsa B , Srivatsa S , Johnson KL , Samura O , Lee SL , Bianchi DW . Microchimerism of presumed fetal origin in adult female thyroid specimens . Lancet2001; 358: 2034–2038 .
31.
Johnson KL , McAlindon TE , Mulcahy E , Bianchi DW . Microchimerism in a female patient with systemic lupus erythematosus . Arthritis Rheum2001; 44: 2107–2111 .
32.
Toda I , Kuwana M , Tsubota K , Kawakami Y . Lack of evidence for an increased microchimerism in the circulation of patient with Sjogren's syndrome . Ann Rheum Dis2001; 60: 248–253 .
33.
Aractingi S , Sibilia J , Meignin V et al. Presence of microchimerism in labial salivary glands in systemic sclerosis but not in sjogren's syndrome . Arthritis Rheum2002; 46: 1039–1043 .
34.
Artlett C , Welsh K , Black C , Jimenz SA . Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis . Immunogenetics1997; 47: 17–22 .
35.
Lambert N , Distler O , Muller-Ladner U , Tylee TS , Furst DE , Nelson JL . HLA DQA1*0501 is associated with diffuse systemic sclerosis in men . Arthritis Rheum2000; 43: 2005–2010 .
36.
Reed AM , Picornell YJ , Harwood A , Kredich DW . Chimerism in children with juvenile dermatomyositis . Lancet2000; 356: 2156–2157 (Research letter).
37.
Artlett CM , Ramos R , Jiminez SA , Patterson K , Miller FW , Rider LG . Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies . Lancet2000; 356: 2155–2156 (Research letter).
38.
Gleichman E , Van Elven H , Van der Veen JP . A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation . Eur J Immunol1982; 12: 152–155 .
39.
Buyon JP , Brucato A . Neonatal lupus . Sem Clin Immunol1998; 1: 245–259 .
40.
Hakim FT , Mackall CL . The immune system: effector and target of graft-versus-host disease. In: Ferrara JL , Deeg HJ , Burakof ST (eds). Graft-vs-Host Disease, 2nd edn.Marcel Dekker: New York , 1997, pp 274–289.
41.
Sayegh MH , Carpenter CB . Role of indirect allorecognition in allograft rejection . Int Rev Immunol1996; 13: 221–229 .
42.
Miller RG . The veto phenomenon and T-cell regulation . Immunol Today1986; 7: 112–114 .
43.
Nelson, JL . Pregnancy and microchimerism in autoimmune disease: protector or insurgent?Arthritis Rheum2002; 46: 291–297 .
